Therefore, we have measured MMP-9/NGAL activity in glioma tissue and urine samples collected before and after surgery of glioma patient to assess the relationship of MMP-9/NGAL activity levels and disease progression and therapeutic response. Here, MMP9 is linked to central nervous system cancer.